Companies: 10,795·Total market cap: $144.5T

IO Biotech, Inc.

IO Biotech, Inc.

IOBTNASDAQHealthcare

$0.01

$-0.00(-27.59%)

Market Cap$885690

P/E Ratio—

52W High$2.79

52W Low$0.01231

Avg Volume20.0M

Open$0.02

Beta0.89

Net Income Financials Revenue

IO Biotech, Inc. (IOBT) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

IOBT · net income · updated Jun 9, 2026

Core profitability metrics

IOBT · net income · margin · TTM · CAGR

Net income was −$95.5M for FY2024 (fiscal year ending 2024-12-31), down 10.9% year-over-year. Net profit margin was —.

FY2024 Net Income−$95.5M▼ -10.9% YoY

Trailing 12M (TTM)−$88.3Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change-10.9%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · IOBT net income history · IOBT profit margin

Annual net income data

IOBT · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2024Loss−$95.5M▼ 10.9%—$0

FY2023Loss−$86.1M▼ 20.5%—$0

FY2022Loss−$71.5M▼ 5.3%—$0

FY2021Loss−$67.9M▼ 463.7%—$0

FY2020Loss−$12.0M▼ 12.0%—$0

Net income vs peers (Healthcare)

IOBT vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

IO Biotech, Inc.YOU

IOBT

−$95.5M-10.9%—

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

IO Biotech, Inc. (IOBT) reported net income of −$95.5M for FY2024 (fiscal year ending 2024-12-31), down 10.9% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

IO Biotech, Inc. has not yet achieved annual profitability based on available data (6 fiscal years). The company has reported net losses across all available periods.

IO Biotech, Inc.'s net profit margin was — for FY2024, based on the latest annual results.

Investors sometimes search for "IO Biotech, Inc. net worth" — the company's market capitalization is a separate figure from IOBT net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

IOBT net income · 4 questions

IO Biotech, Inc. is not currently profitable on an annual basis. The company reported a net loss of $95.5M for FY2024.

is IOBT profitabledoes IOBT make a profitIOBT profitabilityIOBT profitable company

▸ Source: FMP /income-statement · GAAP · IO Biotech, Inc. · IO Biotech, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026